Down-regulation of fibroblast growth factor 2 and its co-receptors heparan sulfate proteoglycans by resveratrol underlies the improvement of cardiac dysfunction in experimental diabetes (2017)
- Authors:
- Autor USP: MANSUR, ANTONIO DE PADUA - FM
- Unidade: FM
- DOI: 10.1016/j.jnutbio.2016.11.015
- Subjects: FATORES DE CRESCIMENTO DE FIBROBLASTOS; RATOS; DOENÇAS CARDÍACAS; PROTEOGLICANAS
- Language: Inglês
- Imprenta:
- Source:
- Título: Journal of Nutritional Biochemistry
- ISSN: 0955-2863
- Volume/Número/Paginação/Ano: v. 40, p. 219-227, 2017
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
STRUNZ, Célia Maria Cássaro et al. Down-regulation of fibroblast growth factor 2 and its co-receptors heparan sulfate proteoglycans by resveratrol underlies the improvement of cardiac dysfunction in experimental diabetes. Journal of Nutritional Biochemistry, v. 40, p. 219-227, 2017Tradução . . Disponível em: https://doi.org/10.1016/j.jnutbio.2016.11.015. Acesso em: 16 fev. 2026. -
APA
Strunz, C. M. C., Roggerio, A., Cruz, P. L., Pacanaro, A. P., Salemi, V. M. C., Benvenuti, L. A., et al. (2017). Down-regulation of fibroblast growth factor 2 and its co-receptors heparan sulfate proteoglycans by resveratrol underlies the improvement of cardiac dysfunction in experimental diabetes. Journal of Nutritional Biochemistry, 40, 219-227. doi:10.1016/j.jnutbio.2016.11.015 -
NLM
Strunz CMC, Roggerio A, Cruz PL, Pacanaro AP, Salemi VMC, Benvenuti LA, Mansur A de P, Irigoyen MC. Down-regulation of fibroblast growth factor 2 and its co-receptors heparan sulfate proteoglycans by resveratrol underlies the improvement of cardiac dysfunction in experimental diabetes [Internet]. Journal of Nutritional Biochemistry. 2017 ; 40 219-227.[citado 2026 fev. 16 ] Available from: https://doi.org/10.1016/j.jnutbio.2016.11.015 -
Vancouver
Strunz CMC, Roggerio A, Cruz PL, Pacanaro AP, Salemi VMC, Benvenuti LA, Mansur A de P, Irigoyen MC. Down-regulation of fibroblast growth factor 2 and its co-receptors heparan sulfate proteoglycans by resveratrol underlies the improvement of cardiac dysfunction in experimental diabetes [Internet]. Journal of Nutritional Biochemistry. 2017 ; 40 219-227.[citado 2026 fev. 16 ] Available from: https://doi.org/10.1016/j.jnutbio.2016.11.015 - Biochemical markers of muscle damage and high serum concentration of creatine kinase in patients on statin therapy
- Resveratrol attenuates fibrosis and alters signaling pathways in diabetic cardiac and skeletal muscles and adipose tissue without reversing structural damage
- Mortalidade por Doenças Cardiovasculares em Mulheres e Homens nas cinco Regiões do Brasil, 1980-2012
- Warfarin doses for anticoagulation therapy in elderly patients with chronic atrial fibrillation
- Na mulher: é diferente do homem?
- Randomized study of 30 days of resveratrol and caloric restriction on serum levels of sirtuin-1 in healthy subjects
- Gender differences in serum CK-MB mass levels in healthy Brazilian subjects
- Panorama da mortalidade por doenças cardiovasculares no Brasil e no Mundo
- Changes in cardiac heparan sulfate proteoglycan expression and streptozotocin-induced diastolic dysfunction in rats
- Prevenção primária das doenças cardiovasculares
Informações sobre o DOI: 10.1016/j.jnutbio.2016.11.015 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
